<i>MiR-155</i> -targeted IcosL controls tumor rejection
Esmerina Tili(The Ohio State University), Carlo M. Croce(The Ohio State University)
Cited by 11
Related Papers
The role of MicroRNAs in human cancer
|Signal Transduction and Targeted Therapy|2016|2.5k
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
|Proceedings of the National Academy of Sciences|2004|1.3k
MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior
|Journal of Clinical Oncology|2006|778
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives
|Cell Death and Differentiation|2009|648